Abstract:Human sirtuins play important roles in various cellular events including DNA repair, gene silencing, mitochondrial biogenesis, insulin secretion as well as apoptosis. They regulate a wide array of protein and enzyme targets through their NAD+‐dependent deacetylase activities. Sirtuins are also thought to mediate the beneficial effects of low‐calorie intake to extend longevity in diverse organisms from yeast to mammals. Small molecules mimicking calorie restriction to stimulate sirtuin activity are attractive therapeutics against age‐related disorders such as cardiovascular diseases, diabetes and neurodegeneration. Little is known about one of the mitochondrial sirtuins, SIRT5. SIRT5 has emerged as a critical player in maintaining cardiac health and neuronal viability upon stress, and functions as a tumor suppressor in a context‐specific manner. Much has been debated about whether SIRT5 has evolved away from being a deacetylase because of its weak catalytic activity, especially in the in vitro testing. We have, for the first time, identified a SIRT5‐selective allosteric activator, nicotinamide riboside (NR). It can increase SIRT5 catalytic efficiency with different synthetic peptide substrates. The mechanism of action was further explored using a combination of molecular biology and biochemical strategies. Based on the existing structural biology information, the NR binding site was also mapped out. These activators are powerful chemical probes for the elucidation of cellular regulations and biological functions of SIRT5. The knowledge gained in the current study can be used to guide the design and synthesis of more potent, isotype‐selective SIRT5 activators, and to develop them into therapeutics for metabolic disorders and age‐related diseases.

Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5

Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology

Overview of SIRT5 as a potential therapeutic target: Structure, function and inhibitors

Sirtuin 5: a review of structure, known inhibitors and clues for developing new inhibitors

Emerging Roles of SIRT5 in Metabolism, Cancer, and SARS-CoV-2 Infection

Activation and inhibition of sirtuins: From bench to bedside

Structure-based Discovery of New Selective Small-Molecule Sirtuin 5 Inhibitors.

Discovery of new human Sirtuin 5 inhibitors by mimicking glutaryl-lysine substrates

Nicotinamide Riboside Activates SIRT5 Deacetylation

Mechanism-Based Inhibitors of the Human Sirtuin 5 Deacylase: Structure-Activity Relationship, Biostructural, and Kinetic Insight

Current Trends in Sirtuin Activator and Inhibitor Development

The (patho)physiological roles of the individual deacylase activities of a sirtuin

New ε-N-thioglutaryl-lysine derivatives as SIRT5 inhibitors: Chemical synthesis, kinetic and crystallographic studies

Sirt5 is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase

SIRT5 Deacylates Metabolism-Related Proteins and Attenuates Hepatic Steatosis in Ob/ob Mice.

Research progress on Sirtuins (SIRTs) family modulators

Small Molecules as SIRT Modulators

SIRT1 Activation by Natural Phytochemicals: An Overview

Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer

Identification of 2-hydroxybenzoic acid derivatives as selective SIRT5 inhibitors

A fluorometric assay of SIRT1 deacetylation activity through quantification of nicotinamide adenine dinucleotide.